CD40 and neoplasm: We established an experimental model of therapy-induced hemorrhagic tumor necrosis by treating GFP-MC38 tumor–bearing mice with a single injection of the anti-CD40 agonist antibody FGK4.5 seven days after subcutaneous tumor cell injection (Figure 1C).